Article citationsMore >>

Frumovitz M., Munsell M. F., Burzawa J. K., et al. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecologic Oncology. 2017; 144(1): 46–50.

has been cited by the following article:

Article

Vaginal Small Cell Neuroendocrine Carcinoma: A Case Report

1Department of OBGYN, Mount Sinai South Nassau, Oceanside, NY

2Optum Health, Baldwin, NY


American Journal of Medical Case Reports. 2024, Vol. 12 No. 8, 127-130
DOI: 10.12691/ajmcr-12-8-6
Copyright © 2024 Science and Education Publishing

Cite this paper:
Tohar Lev, Electra Korn, Lisa Turri, Nicholas Tarricone. Vaginal Small Cell Neuroendocrine Carcinoma: A Case Report. American Journal of Medical Case Reports. 2024; 12(8):127-130. doi: 10.12691/ajmcr-12-8-6.

Correspondence to: Tohar  Lev, Department of OBGYN, Mount Sinai South Nassau, Oceanside, NY. Email: tohar.kochavlev@snch.org

Abstract

We report a case of small cell neuroendocrine carcinoma of the vagina treated with primary resection with positive margins and subsequent chemoradiation. This rare case highlights the importance of a thorough gynecologic exam, full evaluation for any and all abnormal findings, and a comprehensive care team.

Keywords